For decades, the field of immunology was a black box. Leading experts in science and medicine had only a basic understanding of the powerful complexity of the human immune system. Everything changed in 1983 when a...
Author - Rodalyn Guinto
Technology is ready to confront climate change — are we?
2019 is proving to be a historic year for climate change in many ways. One of these significant moments happened in February when New York Representative Alexandria Ocasio-Cortez introduced the “Green New Deal” —...
Programmed for safety: How Synvivia is commercializing biocontainment technology
Gabriel Lopez is the founder and CEO of Synvivia, a startup in the San Francisco Bay Area that makes ON-OFF switches for engineered organisms. During his Ph.D. at UC Berkeley, Gabriel developed a genetically encoded...
The Future is Now. IndieBio’s Demo Day Reflection
For decades people have talked about applying science and technology in the real world. There has been much discussion about how these two fields could be leveraged to make the world a better place. These days, we’re...
IndieBio’s Class Six Presents Next-Gen Therapies — Event Recap
Last Monday, February 19th, I attended my first IndieBio event. The place was packed. And the spirit in the room was chill and welcoming. I found a seat next to a biotech consultant and a developer. We were all curious...
How to close the gap between technological creation and commercialization FAST
Synthetic biology can solve many public problems plaguing our communities today. From food insecurity and killer diseases to climate change, synthetic biology is smashing skepticism and showing the world that not only...
